Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
clindamycin phosphate + benzoyl peroxide
- Development stage
- Approved
- Lead developer
- Dow
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
A fixed-dose combination topical gel containing clindamycin phosphate (an antibiotic) and benzoyl peroxide (an antiseptic) used for the treatment of inflammatory acne vulgaris in patients 12 years and older. The combination works by fighting bacteria involved in acne, treating existing blackheads and whiteheads, and reducing red, inflamed acne spots.
- Brand names
- DuacBenzaclinAcanyaOnexton
- Other names
- Clindamycin/benzoyl peroxide
02
Targets
Staphylococcus aureus 50S ribosomal subunit
Beyond the preview
Go deeper on clindamycin phosphate + benzoyl peroxide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on clindamycin phosphate + benzoyl peroxide.